Guoxu Xu

1.1k total citations
27 papers, 794 citations indexed

About

Guoxu Xu is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Guoxu Xu has authored 27 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Ophthalmology, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Guoxu Xu's work include Retinal Diseases and Treatments (16 papers), Retinal Development and Disorders (6 papers) and Retinal Imaging and Analysis (5 papers). Guoxu Xu is often cited by papers focused on Retinal Diseases and Treatments (16 papers), Retinal Development and Disorders (6 papers) and Retinal Imaging and Analysis (5 papers). Guoxu Xu collaborates with scholars based in China and United States. Guoxu Xu's co-authors include Jingfa Zhang, Guo‐Tong Xu, Weiye Li, Yalan Wu, Jingying Xu, Stephen H. Sinclair, Myron Yanoff, Chaoyang Zhang, Lu Luo and Wei Dai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Guoxu Xu

27 papers receiving 780 citations

Peers

Guoxu Xu

OPHTH

RNMI

NEURO

HEMAT

Maria Tikhonenko United States

Stacey Hose United States

Madalina Opreanu United States

Deokho Lee Japan

Natalie Hudson Ireland

Mira M. Sachdeva United States

Dorette Z. Ellis United States

Youde Jiang United States

Kazuhide Kawase Japan

Yasushi Kitaoka Japan

Maria Tikhonenko United States

Guoxu Xu

174 ×0.4

OPHTH

287 ×0.9

75 ×0.4

RNMI

71 ×0.5

NEURO

31 ×0.3

HEMAT

Citations per year, relative to Guoxu Xu Guoxu Xu (= 1×) peers Maria Tikhonenko

Countries citing papers authored by Guoxu Xu

Since Specialization

Citations

This map shows the geographic impact of Guoxu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxu Xu more than expected).

Fields of papers citing papers by Guoxu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxu Xu. The network helps show where Guoxu Xu may publish in the future.

Co-authorship network of co-authors of Guoxu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxu Xu. A scholar is included among the top collaborators of Guoxu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxu Xu. Guoxu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Tingyu, et al.. (2023). Quantitative study of peripapillary retinal nerve fiber layer thickness and peripapillary vessel density in patients with different stages of Parkinson’s disease. International Journal of Ophthalmology. 16(5). 762–769. 4 indexed citations

Qin, Haifeng, Chaoyang Zhang, Dawei Luo, et al.. (2022). Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion. International Journal of Ophthalmology. 15(8). 1296–1304. 12 indexed citations

Zhu, Siquan, et al.. (2022). Posterior scleral contraction to treat myopic traction maculopathy at different stages.. PubMed. 14(1). 389–395. 2 indexed citations

Tang, Lei, Chaoyang Zhang, Qian Yang, et al.. (2021). Melatonin maintains inner blood‐retinal barrier via inhibition of p38/TXNIP/NF‐κB pathway in diabetic retinopathy. Journal of Cellular Physiology. 236(8). 5848–5864. 48 indexed citations

Zhang, Chaoyang, Haifeng Qin, Hai Xie, et al.. (2021). Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema. Frontiers in Physiology. 12. 791442–791442. 14 indexed citations

Zhang, Chaoyang, Hui Lou, Lei Zhang, et al.. (2021). Is Iba-1 protein expression a sensitive marker for microglia activation in experimental diabetic retinopathy?. International Journal of Ophthalmology. 14(2). 200–208. 46 indexed citations

Liu, Dandan, Hua Xu, Chaoyang Zhang, et al.. (2020). Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. Life Sciences. 259. 118273–118273. 25 indexed citations

Xie, Hai, Chaoyang Zhang, Dandan Liu, et al.. (2020). Erythropoietin protects the inner blood–retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy. Diabetologia. 64(1). 211–225. 69 indexed citations

Wang, Hui, Hui Lou, Yongrong Li, et al.. (2020). Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy. BMC Ophthalmology. 20(1). 260–260. 18 indexed citations

10.

Lou, Hui, Jingfa Zhang, Haibin Tian, et al.. (2019). MicroRNA-24 protects retina from degeneration in rats by down-regulating chitinase-3-like protein 1. Experimental Eye Research. 188. 107791–107791. 17 indexed citations

11.

Zhang, Ji, et al.. (2019). Discussion of orbital fractures surgical reduction with endoscope. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Huang, Jiang, Yi Li, Qin Zhang, et al.. (2018). Combination of Multifocal Electroretinogram and Spectral-Domain OCT Can Increase Diagnostic Efficacy of Parkinson’s Disease. Parkinson s Disease. 2018. 1–7. 17 indexed citations

13.

Cheng, Long, et al.. (2017). The novel cyclophilin D inhibitor compound 19 protects retinal pigment epithelium cells and retinal ganglion cells from UV radiation. Biochemical and Biophysical Research Communications. 487(4). 807–812. 13 indexed citations

14.

Xu, Hua, Limei Zhang, Limin Gu, et al.. (2014). Subretinal Delivery of AAV2-Mediated Human Erythropoietin Gene Is Protective and Safe in Experimental Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 55(3). 1519–1519. 33 indexed citations

15.

Jin, Ji, Guoxu Xu, & Zhilan Yuan. (2014). Influence of the Hypothalamic Arcuate Nucleus on Intraocular Pressure and the Role of Opioid Peptides. PLoS ONE. 9(4). e82315–e82315. 17 indexed citations

16.

Yu, Gehua, et al.. (2013). Expression of insulin-like growth factor 1 receptor in rat retina following optic nerve injury. Acta Ophthalmologica. 91(6). e427–e431. 17 indexed citations

17.

Chu, Qing, Jingfa Zhang, Yalan Wu, et al.. (2010). Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin. Clinical and Experimental Ophthalmology. 39(2). 142–151. 10 indexed citations

18.

Mou, Lisha, Weiye Li, Lei Xia, et al.. (2010). Identification of Vimentin as a Novel Target of HSF4 in Lens Development and Cataract by Proteomic Analysis. Investigative Ophthalmology & Visual Science. 51(1). 396–396. 27 indexed citations

19.

Shen, Jianfeng, Yalan Wu, Jingying Xu, et al.. (2010). ERK- and Akt-Dependent Neuroprotection by Erythropoietin (EPO) against Glyoxal-AGEs via Modulation of Bcl-xL, Bax, and BAD. Investigative Ophthalmology & Visual Science. 51(1). 35–35. 102 indexed citations

20.

Zhang, Jingfa, Yalan Wu, Jingying Xu, et al.. (2008). Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacologica Sinica. 29(11). 1383–1390. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact